Residual gadolinium from MRI contrast agents in the brain: A health risk assessment

0Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Gadolinium based contrast agents are commonly used as MRI contrast agents. Gadolinium is toxic to living organisms and it is used as a contrast agent due to its ability to impart a chelate structure. Gadolinium contrast agents have been used safely for a long time ; however, unfortunately, in recent years we have several reports that gadolinium contrast agents remain in the brain. This revelation is presently drawing world wide attention as to whether the little gadolinium that remains in the human body is harmful or not.

Cite

CITATION STYLE

APA

Kanda, T. (2017). Residual gadolinium from MRI contrast agents in the brain: A health risk assessment. Japanese Journal of Neurosurgery, 26(11), 776–781. https://doi.org/10.7887/jcns.26.776

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free